Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1204 participants.
Also called NCT07454707
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,204 participants
- Registry
-
NCT07454707
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT07454707. Randomized; single masking; primary purpose prevention. Start 2026-11 (anticipated); primary completion 2031-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
- Acronym
- STROKE75+
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- Edoxaban 15 mg
- Intervention (Drug)
- Aspirin or clopidogrel
- Lead sponsor
- Sunnybrook Health Sciences Centre
Record details
- Record id
cardio:ct-nct07454707- Content hash
eb6de9382fdcb765f65024594f94deaf3321c3076d73563b9cf9ddda2dd470c3